Hot Features
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP | Institution | 6 184 134 | 7,88% | US$ 29,56M | 2026-03-31 |
| Suvretta Capital Management, LLC | Institution | 5 674 778 | 7,23% | US$ 27,13M | 2026-04-06 |
| BlackRock, Inc. | Institution | 5 110 871 | 6,51% | US$ 24,43M | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 5 050 211 | 6,43% | US$ 24,14M | 2026-03-31 |
| RA Capital Management, L.P. | Institution | 5 000 000 | 6,37% | US$ 23,90M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 5 000 000 | 6,37% | US$ 23,90M | 2025-10-20 |
| Janus Henderson Group plc | Institution | 4 976 429 | 6,34% | US$ 23,79M | 2026-03-31 |
| Averill Master Fund, Ltd. | Institution | 4 827 730 | 6,15% | US$ 23,08M | 2026-04-06 |
| Vestal Point Capital, LP | Institution | 4 475 000 | 5,70% | US$ 21,39M | 2026-03-31 |
| Frazier Life Sciences Management, LP | Institution | 4 424 725 | 5,64% | US$ 21,15M | 2026-03-31 |
| Affinity Healthcare Fund, LP | Institution | 4 350 358 | 5,54% | US$ 20,79M | 2026-01-22 |
| Paradigm BioCapital International Fund Ltd. | Institution | 4 207 159 | 5,36% | US$ 20,11M | 2025-12-31 |
| Citadel Advisors LLC | Institution | 3 834 999 | 4,88% | US$ 18,33M | 2026-03-31 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 3 698 271 | 4,71% | US$ 17,68M | 2025-12-31 |
| OrbiMed Advisors LLC | Institution | 3 602 450 | 4,59% | US$ 17,22M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 3 568 242 | 4,54% | US$ 17,06M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 3 007 093 | 3,83% | US$ 14,37M | 2026-03-31 |
| Longitude Capital Management Co., LLC | Institution | 2 765 381 | 3,52% | US$ 13,22M | 2025-09-30 |
| Longitude Venture Partners IV, L.P. | Institution | 2 765 381 | 3,52% | US$ 13,22M | 2025-09-30 |
| Woodline Partners LP | Institution | 2 750 532 | 3,50% | US$ 13,15M | 2026-03-31 |
| Janus Henderson Biotech Innovation Master Fund Limited | Institution | 2 683 874 | 3,42% | US$ 12,83M | 2025-03-31 |
| Mizuho Financial Group, Inc. | Institution | 2 203 631 | 2,81% | US$ 10,53M | 2025-03-31 |
| Integrated Core Strategies (US) LLC | Institution | 2 065 700 | 2,63% | US$ 9,87M | 2025-09-30 |
| Avoro Capital Advisors LLC | Institution | 1 875 000 | 2,39% | US$ 8,96M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 1 680 449 | 2,14% | US$ 8,03M | 2026-03-31 |
| Millennium Management LLC | Institution | 1 612 780 | 2,05% | US$ 7,71M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 1 589 585 | 2,02% | US$ 7,60M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1 513 777 | 1,93% | US$ 7,24M | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 1 467 350 | 1,87% | US$ 7,01M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 1 418 916 | 1,81% | US$ 6,78M | 2026-03-31 |
| Nantahala Capital Management, LLC | Institution | 1 200 000 | 1,53% | US$ 5,74M | 2026-03-31 |
| 683 Capital Management, LLC | Institution | 1 200 000 | 1,53% | US$ 5,74M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 1 103 584 | 1,41% | US$ 5,28M | 2026-03-31 |
| Octagon Capital Advisors LP | Institution | 1 100 000 | 1,40% | US$ 5,26M | 2026-03-31 |
| Lundbeckfonden BioCapital | Institution | 942 671 | 1,20% | US$ 4,51M | 2024-09-30 |
| Spruce Street Capital LP | Institution | 928 593 | 1,18% | US$ 4,44M | 2026-03-31 |
| Blackstone Alternative Asset Management L.P. | Institution | 904 959 | 1,15% | US$ 4,33M | 2026-03-31 |
| Frazier Life Sciences Public Overage Fund, L.P. | Institution | 624 804 | 0,80% | US$ 2,99M | 2025-05-28 |
| Vanguard Portfolio Management, LLC | Institution | 577 192 | 0,74% | US$ 2,76M | 2026-03-31 |
| Goldman Sachs Asset Management, L.P. | Institution | 530 969 | 0,68% | US$ 2,54M | 2026-03-31 |
| Ikarian Capital, LLC | Institution | 513 011 | 0,65% | US$ 2,45M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 493 666 | 0,63% | US$ 2,36M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.